UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.231

Sortiert nach

Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition)

International journal of urology, 2015-01, Vol.22 (1), p.3-13

2015

Volltextzugriff (PDF)

Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)

International journal of urology, 2022-07, Vol.29 (7), p.639-640

2022

Volltextzugriff (PDF)

Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions

European radiology, 2021-02, Vol.31 (2), p.875-883

2021

Volltextzugriff (PDF)

Sulfasalazine could modulate the CD44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer

Cancer science, 2019-04, Vol.110 (4), p.1431-1441

2019

Volltextzugriff (PDF)

Editorial Comment to Incidence and location of perioperative deep vein thrombosis in patients with bladder cancer undergoing radical cystectomy

International journal of urology, 2022-03, Vol.29 (3), p.264-265

2022

Volltextzugriff (PDF)

Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision

International journal of urology, 2020-09, Vol.27 (9), p.702-709

2020

Volltextzugriff (PDF)

Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma

Cancer science, 2020-10, Vol.111 (10), p.3639-3652

2020

Volltextzugriff (PDF)

Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)

World journal of urology, 2017-03, Vol.35 (3), p.379-387

2017

Volltextzugriff (PDF)

Editorial Comment to Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched‐pair analysis in a multicenter cohort

International journal of urology, 2021-06, Vol.28 (6), p.664-664

2021

Volltextzugriff (PDF)

Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan

Japanese journal of clinical oncology, 2016-08, Vol.46 (8), p.768-774

2016

Volltextzugriff (PDF)

Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

Cancer, 2009-03, Vol.115 (6), p.1224-1233

2009

Volltextzugriff (PDF)

Editorial Comment to Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan

International journal of urology, 2021-01, Vol.28 (1), p.60-61

2021

Volltextzugriff (PDF)

Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching

Annals of surgical oncology, 2021-01, Vol.28 (1), p.465-473

2021

Volltextzugriff (PDF)

A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer

IJU case reports, 2023-01, Vol.6 (1), p.5-7

2023

Volltextzugriff (PDF)

Bacillus Calmette–Guérin‐unresponsive non‐muscle‐invasive bladder cancer: Its definition and future therapeutic strategies

International journal of urology, 2020-02, Vol.27 (2), p.108-116

2020

Volltextzugriff (PDF)

Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history

Scientific reports, 2021-10, Vol.11 (1), p.20675-20675, Article 20675

2021

Volltextzugriff (PDF)

Editorial Comment to Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study

International journal of urology, 2014-05, Vol.21 (5), p.460-460

Kikuchi, Eiji

2014

Volltextzugriff (PDF)

Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer

Molecular cancer therapeutics, 2015-09, Vol.14 (9), p.2112-2120

2015

Volltextzugriff (PDF)

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer

BMC cancer, 2018-01, Vol.18 (1), p.113-113, Article 113

2018

Volltextzugriff (PDF)

Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers

Cancer science, 2016-09, Vol.107 (9), p.1338-1344

2016

Volltextzugriff (PDF)

Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma

International journal of urology, 2016-04, Vol.23 (4), p.284-298

2016

Volltextzugriff (PDF)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma

Cancer science, 2021-03, Vol.112 (3), p.1084-1094

2021

Volltextzugriff (PDF)

TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells

Laboratory investigation, 2019-11, Vol.99 (11), p.1702-1713

2019

Volltextzugriff (PDF)

Dual PI3K/mTOR Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer

The Journal of urology, 2014, Vol.191 (1), p.227-234

2014

Volltextzugriff (PDF)

Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time

European urology, 2014-08, Vol.66 (2), p.361-370

2014

Volltextzugriff (PDF)

1 – 25 von 1.231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.020)
Mit Volltextzugriff
(917)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.129)
Japanisch
(378)
Koreanisch
(1)
Deutsch
(1)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary - Japanese Urological Association, 2014 edition)

Editorial Comment from Dr Hayakawa and Dr Kikuchi to Bladder cancer prospective cohort study on high‐risk non‐muscle invasive bladder cancer after photodynamic diagnosis‐assisted transurethral resection of the bladder tumor (BRIGHT study)

Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions

Sulfasalazine could modulate the CD44v9‐xCT system and enhance cisplatin‐induced cytotoxic effects in metastatic bladder cancer

Editorial Comment to Incidence and location of perioperative deep vein thrombosis in patients with bladder cancer undergoing radical cystectomy

Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision

Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma

Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)

Editorial Comment to Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched‐pair analysis in a multicenter cohort

Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan

Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

Editorial Comment to Prognostic impact of non‐urothelial carcinoma of the upper urinary tract: Analysis of hospital‐based cancer registry data in Japan

Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching

A case of pseudoprogression in avelumab maintenance therapy for metastatic bladder cancer

Bacillus Calmette–Guérin‐unresponsive non‐muscle‐invasive bladder cancer: Its definition and future therapeutic strategies

Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history

Editorial Comment to Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: A prospective study

Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer

Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers

Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma

TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells

Dual PI3K/mTOR Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer

Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time

Suchergebnisse filtern